Cargando…
Leveraging various extracellular matrix levels to assess prognosis and sensitivity to immunotherapy in patients with ovarian cancer
BACKGROUND: Ovarian cancer (OC) is the fifth leading cause of cancer-related deaths among women. Late diagnosis and heterogeneous treatment result in a poor prognosis for patients with OC. Therefore, we aimed to develop new biomarkers to predict accurate prognoses and provide references for individu...
Autores principales: | Huang, Youqun, Lei, Xingxing, Sun, Lisha, Liu, Yu, Yang, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203472/ https://www.ncbi.nlm.nih.gov/pubmed/37228494 http://dx.doi.org/10.3389/fonc.2023.1163695 |
Ejemplares similares
-
The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015) -
Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy
por: Liu, Jiayang, et al.
Publicado: (2023) -
The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors
por: Petersen, Elena V., et al.
Publicado: (2020) -
Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response
por: Yang, Zhi, et al.
Publicado: (2021) -
Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)